Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., . . . Caers, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica.
Dyfyniad Arddull ChicagoMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Dyfyniad MLAMuller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.